FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1921572183> ?p ?o ?g. }

• W1921572183 endingPage "1550" @default.
• W1921572183 startingPage "1540" @default.
• W1921572183 abstract "An international double-blind randomized placebo controlled study evaluated the safety and efficacy of four doses of a new sustained release naloxone capsule to treat Opioid Induced Constipation (OIC).Forty patients taking opioids for noncancer related pain, and experiencing OIC, were randomized into 4 cohorts of 10 patients. A multiple ascending dose design was used to evaluate the safety and efficacy of 2.5 mg, 5 mg, 10 mg, and 20 mg naloxone sustained release (NSR) capsules vs placebo. Drug was given once-daily for 3 weeks followed by twice daily (bid) dosing between weeks 4 and 6.The incidence of treatment emergent adverse events was highest in the placebo group. The incidence of adverse events among the four active treatment groups were similar. There were no serious adverse events. The number of severe events was low overall but highest in the placebo group. Significant improvements were seen in Spontaneous Bowel Movements with 5 mg, 10 mg, and 20 mg NSR capsules. Mean change in SBMs from baseline of 2.21 (P = 0.052), 2.37 (P = 0.032); 4.11 (P = 0.0005); 5.19 (<0.0001) was noted with NSR 2.5 mg, 5 mg, 10 mg, and 20 mg, respectively, when taken once daily, compared with 1.38 (P = 0.2) for patients on placebo therapy. No changes in subjective or objective measures of opioid withdrawal as measured by the Subjective Opioid Withdrawal Scale or Clinical Opioid Withdrawal Scale were observed. There was no increase in patient reported pain as measured daily using a visual analogue scale.This Phase II study has shown that using a new sustained release formulation to deliver oral naloxone to the colon allows successful treatment of OIC without comprising the desired opioid effects." @default.
• W1921572183 created "2016-06-24" @default.
• W1921572183 creator A5000973623 @default.
• W1921572183 creator A5043735484 @default.
• W1921572183 creator A5080748196 @default.
• W1921572183 creator A5080844139 @default.
• W1921572183 creator A5083964295 @default.
• W1921572183 creator A5086106244 @default.
• W1921572183 date "2015-08-01" @default.
• W1921572183 modified "2023-09-26" @default.
• W1921572183 title "New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects" @default.
• W1921572183 cites W106147234 @default.
• W1921572183 cites W1493383013 @default.
• W1921572183 cites W1502891136 @default.
• W1921572183 cites W1966250447 @default.
• W1921572183 cites W1967886432 @default.
• W1921572183 cites W1973640136 @default.
• W1921572183 cites W1976200263 @default.
• W1921572183 cites W1979282061 @default.
• W1921572183 cites W1980448638 @default.
• W1921572183 cites W1981620647 @default.
• W1921572183 cites W1995239938 @default.
• W1921572183 cites W1996075855 @default.
• W1921572183 cites W1996808926 @default.
• W1921572183 cites W2003081769 @default.
• W1921572183 cites W2032381327 @default.
• W1921572183 cites W2040109649 @default.
• W1921572183 cites W2048312111 @default.
• W1921572183 cites W2052807712 @default.
• W1921572183 cites W2064201279 @default.
• W1921572183 cites W2064268957 @default.
• W1921572183 cites W2074029198 @default.
• W1921572183 cites W2097910464 @default.
• W1921572183 cites W2104191533 @default.
• W1921572183 cites W2112773265 @default.
• W1921572183 cites W2113250961 @default.
• W1921572183 cites W2124990868 @default.
• W1921572183 cites W2128848460 @default.
• W1921572183 cites W2143221646 @default.
• W1921572183 cites W2889306943 @default.
• W1921572183 doi "https://doi.org/10.1111/pme.12775" @default.
• W1921572183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26110375" @default.
• W1921572183 hasPublicationYear "2015" @default.
• W1921572183 type Work @default.
• W1921572183 sameAs 1921572183 @default.
• W1921572183 citedByCount "20" @default.
• W1921572183 countsByYear W19215721832015 @default.
• W1921572183 countsByYear W19215721832016 @default.
• W1921572183 countsByYear W19215721832017 @default.
• W1921572183 countsByYear W19215721832018 @default.
• W1921572183 countsByYear W19215721832020 @default.
• W1921572183 countsByYear W19215721832022 @default.
• W1921572183 countsByYear W19215721832023 @default.
• W1921572183 crossrefType "journal-article" @default.
• W1921572183 hasAuthorship W1921572183A5000973623 @default.
• W1921572183 hasAuthorship W1921572183A5043735484 @default.
• W1921572183 hasAuthorship W1921572183A5080748196 @default.
• W1921572183 hasAuthorship W1921572183A5080844139 @default.
• W1921572183 hasAuthorship W1921572183A5083964295 @default.
• W1921572183 hasAuthorship W1921572183A5086106244 @default.
• W1921572183 hasBestOaLocation W19215721831 @default.
• W1921572183 hasConcept C120665830 @default.
• W1921572183 hasConcept C121332964 @default.
• W1921572183 hasConcept C126322002 @default.
• W1921572183 hasConcept C142724271 @default.
• W1921572183 hasConcept C168563851 @default.
• W1921572183 hasConcept C170493617 @default.
• W1921572183 hasConcept C197934379 @default.
• W1921572183 hasConcept C204787440 @default.
• W1921572183 hasConcept C27081682 @default.
• W1921572183 hasConcept C2777288759 @default.
• W1921572183 hasConcept C2778750930 @default.
• W1921572183 hasConcept C2781063702 @default.
• W1921572183 hasConcept C2781112942 @default.
• W1921572183 hasConcept C42219234 @default.
• W1921572183 hasConcept C61511704 @default.
• W1921572183 hasConcept C71924100 @default.
• W1921572183 hasConceptScore W1921572183C120665830 @default.
• W1921572183 hasConceptScore W1921572183C121332964 @default.
• W1921572183 hasConceptScore W1921572183C126322002 @default.
• W1921572183 hasConceptScore W1921572183C142724271 @default.
• W1921572183 hasConceptScore W1921572183C168563851 @default.
• W1921572183 hasConceptScore W1921572183C170493617 @default.
• W1921572183 hasConceptScore W1921572183C197934379 @default.
• W1921572183 hasConceptScore W1921572183C204787440 @default.
• W1921572183 hasConceptScore W1921572183C27081682 @default.
• W1921572183 hasConceptScore W1921572183C2777288759 @default.
• W1921572183 hasConceptScore W1921572183C2778750930 @default.
• W1921572183 hasConceptScore W1921572183C2781063702 @default.
• W1921572183 hasConceptScore W1921572183C2781112942 @default.
• W1921572183 hasConceptScore W1921572183C42219234 @default.
• W1921572183 hasConceptScore W1921572183C61511704 @default.
• W1921572183 hasConceptScore W1921572183C71924100 @default.
• W1921572183 hasIssue "8" @default.
• W1921572183 hasLocation W19215721831 @default.
• W1921572183 hasLocation W19215721832 @default.
• W1921572183 hasOpenAccess W1921572183 @default.
• W1921572183 hasPrimaryLocation W19215721831 @default.

• next